Mr. Yang’s plan would also allow forced licensing of drugs if companies can’t come to a reasonable agreement with the federal government on prices that match what other countries charge.
He said he would allow importation of prescription drugs from other countries “if all else fails.”
According to his statement, “brand-name prescription drug prices have risen 76 percent over the past six years, and they’re not slowing down.”
“While drug companies complain constantly about the high cost of research, they fail to mention that almost all FDA-approved drugs over the past several years relied on research funded by the National Institute of Health,” he added.
Mr. Yang also accused pharmaceutical companies of exploiting the market “and the American people.”
Read the full news release here.
More articles on pharmacy:
UnitedHealth to acquire struggling specialty pharmacy
Pharmaceutical layoffs up nearly 6% from last year
Larger chunk of hospital drug spending going toward cancer treatments, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
